Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response
Chiara Fabbri, Ladislav Hosák, Rainald Mößner, et al.
The World Journal of Biological Psychiatry (2016) Vol. 18, Iss. 1, pp. 5-28
Open Access | Times Cited: 79

Showing 26-50 of 79 citing articles:

Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal
Wenwei Ren, Xiaoqian Luan, Jie Zhang, et al.
Journal of Affective Disorders (2017) Vol. 221, pp. 165-171
Closed Access | Times Cited: 29
Duloxetine plasma level and antidepressant response
Domenico De Donatis, Vincenzo De Florio, Stefano Porcelli, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 92, pp. 127-132
Closed Access | Times Cited: 29
Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting: study protocol of the OPTIMA-RCT
Johannes Kopf‐Beck, Petra Zimmermann, Samy Egli, et al.
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 27
The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression
Reiji Yoshimura, Naomichi Okamoto, Enkhmurun Chibaatar, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 584-584
Open Access | Times Cited: 9
Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders
Аnastasia Levchenko, Timur Nurgaliev, Alexander Kanapin, et al.
Heliyon (2020) Vol. 6, Iss. 5, pp. e03990-e03990
Open Access | Times Cited: 22
Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity
Maia Ludmila Budziñski, Clara Sokn, Romina P. Gobbini, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 5, pp. 2533-2545
Closed Access | Times Cited: 14
How to choose an antidepressant medication
Adam Bayes, Gordon Parker
Acta Psychiatrica Scandinavica (2018) Vol. 139, Iss. 3, pp. 280-291
Closed Access | Times Cited: 23
Personalized and precision medicine as informants for treatment management of bipolar disorder
Giulio Perugi, Pietro De Rossi, Andrea Fagiolini, et al.
International Clinical Psychopharmacology (2019) Vol. 34, Iss. 4, pp. 189-205
Closed Access | Times Cited: 21
Acceptability of Pharmacogenetic Testing among French Psychiatrists, a National Survey
Benjamin Laplace, Benjamin Calvet, Aurélie Lacroix, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 6, pp. 446-446
Open Access | Times Cited: 18
The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder
Laura Mandelli, Sheng‐Min Wang, Hans‐Jürgen Möller, et al.
Advances in Therapy (2017) Vol. 34, Iss. 3, pp. 713-724
Closed Access | Times Cited: 18
Genetics and pharmacogenetics of mood disorders
Alessandro Serretti
Psychiatria Polska (2017) Vol. 51, Iss. 2, pp. 197-203
Open Access | Times Cited: 17
Understanding the Interplay between Air Pollution, Biological Variables, and Major Depressive Disorder: Rationale and Study Protocol of the DeprAir Study
Elisa Borroni, Angela Cecilia Pesatori, Guido Nosari, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 6, pp. 5196-5196
Open Access | Times Cited: 5
Altered Trek-1 Function in Sortilin Deficient Mice Results in Decreased Depressive-Like Behavior
Sébastien Moréno, Christelle Devader, Mariel Piétri, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 16
The functional variant rs334558 of <em>GSK3B</em> is associated with remission in patients with depressive disorders
Аnastasia Levchenko, Innokentiy S. Losenkov, N. Vyalova, et al.
Pharmacogenomics and Personalized Medicine (2018) Vol. Volume 11, pp. 121-126
Open Access | Times Cited: 15
Associations between the 1438A/G, 102T/C, and rs7997012G/A polymorphisms of HTR2A and the safety and efficacy of antidepressants in depression: a meta-analysis
Yuansheng Wan, Xuejia Zhai, Hong-ai Tan, et al.
The Pharmacogenomics Journal (2020) Vol. 21, Iss. 2, pp. 200-215
Closed Access | Times Cited: 14
Genetische Tests zur Steuerung der Behandlung mit Antidepressiva
Tom Bschor, Christopher Baethge, Christoph Hiemke, et al.
Der Nervenarzt (2017) Vol. 88, Iss. 5, pp. 495-499
Closed Access | Times Cited: 14
Controversies in psychiatry
Florence Thibaut
Dialogues in Clinical Neuroscience (2018) Vol. 20, Iss. 3, pp. 151-152
Open Access | Times Cited: 12
Genetic factors and symptom dimensions associated with antidepressant treatment outcomes: clues for new potential therapeutic targets?
Alfonso Martone, Chiara Possidente, Giuseppe Fanelli, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 1
Pharmacogenomics-assisted treatment versus standard of care in schizophrenia: a systematic review and meta-analysis
Saibal Das, Manoj Kalita, Manabendra Makhal, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
“Now Is a Time for Optimism”: The Politics of Personalized Medicine in Mental Health Research
Jonas Rüppel
Science Technology & Human Values (2019) Vol. 44, Iss. 4, pp. 581-611
Closed Access | Times Cited: 10
Influence of genetic polymorphisms in homocysteine and lipid metabolism systems on antidepressant drug response
Baoyu Yuan, Xiaoyan Sun, Zhi Xu, et al.
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Can Molecular Biology Propose Reliable Biomarkers for Diagnosing Major Depression?
Н Н Иванец, Andrey Svistunov, Vladimir N. Chubarev, et al.
Current Pharmaceutical Design (2020) Vol. 27, Iss. 2, pp. 305-318
Closed Access | Times Cited: 10
Beneficial Pleiotropic Antidepressive Effects of Cardiovascular Disease Risk Factor Interventions in the Metabolic Syndrome
Stephanie J. Frisbee, Sarah Singh, Dwayne N. Jackson, et al.
Journal of the American Heart Association (2018) Vol. 7, Iss. 7
Open Access | Times Cited: 9
Regional gene expression patterns are associated with task‐specific brain activation during reward and emotion processing measured with functional MRI
Arkadiusz Komorowski, Matej Murgaš, Ramón Vidal, et al.
Human Brain Mapping (2022) Vol. 43, Iss. 17, pp. 5266-5280
Open Access | Times Cited: 6
Childhood trauma, inflammatory biomarkers and the presence of a current depressive episode: Is there a relationship in subjects from a population study?
Leonardo Carvalho Oliveira, Natália Wirowski, Pedro Borges de Souza, et al.
Journal of Psychiatric Research (2022) Vol. 158, pp. 255-260
Closed Access | Times Cited: 6

Scroll to top